Barclays PLC Journey Medical Corp Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Journey Medical Corp stock. As of the latest transaction made, Barclays PLC holds 17,566 shares of DERM stock, worth $139,474. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,566
Previous 22,403
21.59%
Holding current value
$139,474
Previous $161,000
22.98%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DERM
# of Institutions
69Shares Held
8.96MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$14.7 Million0.6% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.31MShares$10.4 Million0.05% of portfolio
-
Opaleye Management Inc. Boston, MA971KShares$7.71 Million1.15% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.87 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA615KShares$4.88 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $92.1M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...